
Customize View
Recently disclosed strategic alliances only (within the last two years)
Include Strategic Alliances for:Current subsidiaries



Strategic Alliances

Recently Disclosed Strategic Alliances
Strategic Alliance Name
Primary Industry
Source
Canadian Centre for Vaccinology

IMV Inc. (OTCPK:IMVI.Q) 2022 Form 40-F
Business Description: There is no business description for this company.
Chu De QuEbec - Universite Laval
Research and Consulting Services
IMV Inc. (OTCPK:IMVI.Q) 2023 Form 20-F
Business Description: Noncommercial Research Organization
Dalhousie University
Education Services
IMV Inc. (OTCPK:IMVI.Q) 2023 Form 20-F
Business Description: Dalhousie University operates as a university for offering education services. Its programs include architecture, costume studies, community design, environment, sustainability and society, international food business, and landscape architecture. It also offers undergraduates studies, graduate studies, law, medicine, and dentistry. The institution was founded in 1818 and is based in Halifax, Canada with additional campus in Truro, Canada.
Izaak Walton Killam Health Centre, The
Health Care Facilities
IMV Inc. (OTCPK:IMVI.Q) 2023 Form 20-F
Business Description: There is no business description for this company.
Merck & Co., Inc. (NYSE:MRK)
Pharmaceuticals
IMV Inc. (OTCPK:IMVI.Q) 2023 Form 20-F
Business Description: Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, such as preventive pediatric, adolescent, and adult vaccines. The Animal Health segment discovers, develops, manufactures, and markets veterinary pharmaceuticals, vaccines, and health management solutions and services, as well as digitally connected identification, traceability, and monitoring products. The company serves drug wholesalers and retailers, hospitals, and government agencies; managed health care providers, such as health maintenance organizations, pharmacy benefit managers, and other institutions; and physicians and physician distributors, veterinarians, and animal producers. It has collaborations with AstraZeneca PLC; Bayer AG; Eisai Co., Ltd.; Ridgeback Biotherapeutics LP; and Gilead Sciences, Inc. to jointly develop and commercialize long-acting treatments in HIV, as well as a collaboration with Bionomics to identify novel a7 nAChR PAMs suitable for the treatment of cognitive disorder; and clinical trial collaboration and supply agreement with Ankyra Therapeutics to evaluate ANK-101 in combination with KEYTRUDA (pembrolizumab) in patients with advanced solid tumors. Merck & Co., Inc. was founded in 1891 and is headquartered in Rahway, New Jersey.
Nova Scotia Health Authority
Health Care Facilities
IMV Inc. (OTCPK:IMVI.Q) 2023 Form 20-F
Business Description: Nova Scotia Health Authority operates as a government institution provides health services to Nova Scotians and some specialized services to Maritimers and Atlantic Canadians. It operates hospitals, health centers, and community-based programs across the province. Nova Scotia Health Authority was formerly known as Capital District Health Authority and changed its name to Nova Scotia Health Authority in April, 2015. The institution is based in Halifax, Canada.
The Wistar Institute
Education Services
IMV Inc. (OTCPK:IMVI.Q) 2022 Form 40-F
Business Description: The Wistar Institute is an educational institution.
Université Laval
Education Services
IMV Inc. (OTCPK:IMVI.Q) 2023 Form 20-F
Business Description: Université Laval is an Educational Institution.
*denotes proprietary relationship